Work

Preliminary Data from a Multicenter, Phase II, Randomized, Non-Comparative Clinical Trial of Radiation and Temozolomide with or without Vandetanib in Newly-Diagnosed Glioblastoma (GBM) (S45.006)

Year: 2012

Type: conference-abstract

Source: Neurology

DOI: 10.1212/wnl.78.1_meetingabstracts.s45.006

Authors: E. Lee, T. Batchelor, T. Kaley, D. Schiff, A. Lassman, E. Wong, T. Mikkelsen, B. Purow, J. Drappatz, A. Norden, R. Beroukhim, S. Weiss, B. Alexander, C. McCluskey, M. Gerard, L. Teulings, K. Smith, A. Muzikansky, P. Wen

Institutions: Dana-Farber Brigham Cancer Center, Massachusetts General Hospital, Memorial Sloan Kettering Cancer Center, University of Virginia, Beth Israel Deaconess Medical Center, Henry Ford Hospital, University of Pittsburgh, Brigham and Women's Hospital, Dana-Farber Cancer Institute

Language: English

Topic: Glioma Diagnosis and Treatment

Subfield: Genetics (clinical)

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2083198620

Cites:

Cited by:

Related to: 10